Article info
PDFHepatology
Original article
Tenofovir monotherapy versus tenofovir and entecavir combination therapy in adefovir-resistant chronic hepatitis B patients with multiple drug failure: results of a randomised trial
- Correspondence to Professor Young-Suk Lim, Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea; limys{at}amc.seoul.kr Professor Byung Chul Yoo, Department of Internal Medicine, Konkuk University School of Medicine, 120 Neugdong-ro, Gwangjin-gu, Seoul 143-701, Korea; 20150144{at}kuh.ac.kr
Citation
Tenofovir monotherapy versus tenofovir and entecavir combination therapy in adefovir-resistant chronic hepatitis B patients with multiple drug failure: results of a randomised trial
Publication history
- Received September 13, 2014
- Revised February 16, 2015
- Accepted March 5, 2015
- First published March 23, 2015.
Online issue publication
June 02, 2016
Article Versions
- Previous version (10 May 2016).
- Previous version (10 May 2016).
- Previous version (10 May 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/